RED:NICE TA1002 - Use as an adjunct to diet and other low-density lipoprotein cholesterol
lowering therapies for the treatment of adult and adolescent patients aged ≥12
years with homozygous familial hypercholesterolaemia (Decision date - October 2024)
Red Drug Classifications
1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
8. NHS England commissioned – to be used in line with NHSE commissioning intentions
